Financial Services

With the hire of Kirk Sadler, Red Oak signals a major push to advance its AI-driven platform amid a heated RegTech market and rising regulatory pressure.

With strong revenue, key AI upgrades, and a top Microsoft award, Blue Yonder is solidifying its market lead as global supply chain pressures intensify.

For the 13th straight year, Vena is a CPM leader, now ranked most usable. Discover how its AI and deep Microsoft integration are setting a new industry standard.

A successful over-the-air test of the DVB-S2X waveform on a software-defined modem signals a major leap in flexible, high-speed military communications.

A new strategic alliance aims to bring complex peptide therapies to Europe and India, signaling a shift in global biopharma partnerships and patient access.

A leading fintech company's Q1 charity provides food and a refrigerated truck, tackling growing food insecurity with strategic local partnerships.

A 50-year-old caramel apple giant acquires a TikTok-famous cotton candy brand, signaling a major shift toward experiential, year-round confections.

A Chinese biotech's novel nasal spray flu vaccine enters trials. Its unique design could finally make it safe for the elderly and expand global access.

With its lead drug in Phase 3, Celldex will update investors at three major conferences, highlighting its immunology pipeline and financial strategy.

Universal Corporation appoints Steven Diel, the mind behind its ingredients push, as CFO, signaling a firm commitment to diversification despite headwinds.

Beverly Hills Plastic Surgery® is moving beyond aesthetics with its "Eternal G.L.O.W." series, a year-long program focused on holistic health.

As it marks its 40th year, the legal finance giant's impressive 3.0x return on capital highlights the growing appeal of legal assets as a stable asset class.

Activist investor Impactive Capital nominates four directors to the WEX board, citing years of underperformance and demanding a strategic overhaul.

As ReNew prepares its Q3 FY26 report, all eyes are on the energy giant. Will its performance validate India's green transition and its own manufacturing bet?

A £500,000 philanthropic investment fuels five pioneering research projects at Oxford, aiming to unlock new treatments for a devastating rare disease.

A groundbreaking dual-payload ADC from Kanghong Pharmaceutical has entered clinical trials, a major milestone in oncology accelerated by partner BioDlink.

A new Palm City retail store is more than just a storefront; it's a strategic hub for Vision Marine's plan to dominate the electric yacht tender market.

Hiab's strategic partnership with Manitowoc subsidiary MGX Equipment Services radically expands its US footprint, targeting booming construction markets.

Computational chemistry firm Evogene adds world-renowned experts to guide its ChemPass AI™, aiming to accelerate drug and ag-chemical innovation.

Heart disease is the leading cause of premature death for Canadian women, yet it remains under-diagnosed and under-treated. A national movement is fighting back.